首页|血清CC16、sRAGE水平与ARDS患者疾病转归的相关性及预测价值研究

血清CC16、sRAGE水平与ARDS患者疾病转归的相关性及预测价值研究

扫码查看
目的 探讨血清Clara细胞分泌蛋白16(CC16)、可溶性晚期糖基化终产物受体(sRAGE)水平变化与急性呼吸窘迫综合征(ARDS)患者疾病转归的相关性及预测价值。方法 选取2021年1月至2023年1月灵宝市第二人民医院收治的127例ARDS患者为研究对象,根据ARDS严重程度将患者分为轻度组(39例)、中度组(52例)和重度组(36例)。比较不同严重程度患者及不同疾病转归患者血清CC16、sRAGE水平、氧合指数(PaO2/FiO2)、急性生理学及慢性健康状况Ⅱ(APACHE Ⅱ)评分、序贯器官衰竭评估(SOFA)评分,分析血清CC16、sRAGE水平与PaO2/FiO2、APACHEⅡ评分、SOFA评分及疾病转归的相关性。采用logistic回归分析ARDS患者病死的危险因素,受试者工作特征(ROC)曲线分析血清CC16、sRAGE水平及二者联合检测对ARDS患者病死的预测价值。结果 ARDS不同程度患者入院时血清CC16、sRAGE水平及APACHEⅡ、SOFA评分比较:轻度组<中度组<重度组,PaO2/FiO2比较:轻度组>中度组>重度组,差异均有统计学意义(P<0。05);病死患者入院时血清CC16、sRAGE水平及APACHE Ⅱ、SOFA评分均高于生存患者,而PaO2/FiO2低于生存患者,差异均有统计学意义(P<0。05);患者入院时血清CC16、sRAGE水平与PaO2/FiO2均呈负相关(P<0。05),与APACHE Ⅱ、SOFA评分及疾病转归均呈正相关(P<0。05);入院时血清CC16、sRAGE水平为ARDS患者病死的危险因素,且两指标联合预测ARDS患者病死的ROC曲线下面积大于各单项指标(P<0。05)。结论 ARDS患者血清CC16、sRAGE表达上调,其水平与疾病转归密切相关,二者联合检测可作为临床早期预测转归情况的有效指标。
Correlation between serum CC16 and sRAGE levels and disease outcome of ARDS patients and their predictive value
Objective To investigate the correlation between serum protein 16(CC16),soluble ad-vanced glycation end product receptor(sRAGE)and the disease outcome in patients with acute respiratory distress syndrome(ARDS)and their predictive value.Methods A total of 127 ARDS patients admitted to the Second People's Hospital of lingbao city from January 2021 to January 2023 were selected as the research ob-jects,and the patients were divided into the mild group(39 cases),the moderate group(52 cases)and the se-vere group(36 cases)according to the severity of ARDS.The levels of serum CC16,sRAGE,oxygenation in-dex(PaO2/FiO2),acute physiology and chronic health status Ⅱ(APACHE Ⅱ)scores and sequential organ failure assessment(SOFA)scores were compared between patients with different severity and patients with different disease outcomes,and the correlation between serum CC16,sRAGE levels and PaO2/FiO2,APACHEⅡ scores,SOFA scores and disease outcomes was analyzed.Logistic regression was used to analyze the risk factors of ARDS patients'death,and ROC curve was used to analyze the predictive value of combined detec-tion and each individual of serum CC16 and sRAGE levels for ARDS patients'death.Results Comparison of serum CC16,sRAGE levels,and APACHE Ⅱ,SOFA scores of patients with different degrees of ARDS at ad-mission:the mild group<the moderate group<the severe group,PaO2/FiO2 comparison:the mild group>the moderate group>the severe group,the differences were all statistically significant(P<0.05);Serum CC16,sRAGE level,and APACHE Ⅱ,SOFA scores of the dead patients were higher than those of the survi-ving patients,and PaO2/FiO2 was lower than that of the surviving patients,and the differences were all statis-tically significant(P<0.05);Serum levels of CC16 and sRAGE were negatively correlated with PaO2/FiO2 on admission,and were positively correlatied with APACHEⅡ,SOFA scores,and disease outcome(P<0.05).Serum CC16 and sRAGE levels at admission were risk factors for mortality in ARDS patients.Moreo-ver,the ROC area under the curve of combined detection of two index of the ARDS patients was greater than that of each individual index(P<0.05).Conclusion The expression of serum CC16 and sRAGE in ARDS pa-tients is up-regulated,which is closely related to disease outcome,and can be used as an effective indicator for early clinical predictive to outcome.

Serum Clara cell secreted protein 16Soluble advanced glycation end product receptorAcute respiratory distress syndromeDisease outcomeCombined detectionPredictive

张伟、王辉、张中兴

展开 >

灵宝市第二人民医院重症医学科,河南三门峡 472500

三门峡市中心医院呼吸内科 河南 三门峡 472000

血清Clara细胞分泌蛋白16 可溶性晚期糖基化终产物受体 急性呼吸窘迫综合征 疾病转归 联合检测 预测

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(5)
  • 15